Long-term outcome of steroid-resistant nephrotic syndrome in children

Journal of the American Society of Nephrology

Volumn 28, Issue 10, 2017, Pages 3055-3065

  Trautmann, Agnes ^a   Schnaidt, Sven ^b   Lipska Ziȩtkiewicz, Beata S ^c   Bodria, Monica ^d,e   Ozaltin, Fatih ^f   Emma, Francesco ^g   Anarat, Ali ^h   Melk, Anette ⁱ   Azocar, Marta ^j   Oh, Jun ^k   Saeed, Bassam ^l   Gheisari, Alaleh ^m   Caliskan, Salim ⁿ   Gellermann, Jutta ^o   Higuita, Lina Maria Serna ^p   Jankauskiene, Augustina ^q   Drozdz, Dorota ^r   Mir, Sevgi ^s   Balat, Ayse ^t   Szczepanska, Maria ^u   Paripovic, Dusan ^v   Zurowska, Alexandra ^c   Bogdanovic, Radovan ^w   Yilmaz, Alev ⁿ   Ranchin, Bruno ^x   Baskin, Esra ^y   Erdogan, Ozlem ^z   Remuzzi, Giuseppe ^aa,ab,ac   Firszt Adamczyk, Agnieszka ^ad   Kuzma Mroczkowska, Elzbieta ^ae   Litwin, Mieczyslaw ^af   Murer, Luisa ^ag   Tkaczyk, Marcin ^ah   Jardim, Helena ^ai   Wasilewska, Anna ^aj   Printza, Nikoleta ^ak   Fidan, Kibriya ^al   Simkova, Eva ^am   Borzecka, Halina ^an   Staude, Hagen ^ao   Hees, Katharina ^b   Schaefer, Franz ^a   more..

^a Center for Pediatrics and Adolescent Medicine   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

^d UNIVERSITY OF PARMA   (Italy)

^e G GASLINI INSTITUTE   (Italy)

^f HACETTEPE UNIVERSITY   (Turkey)

^g BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^h CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

ⁱ HANNOVER MEDICAL SCHOOL   (Germany)

^j HOSPITAL LUIS CALVO MACKENNA   (Chile)

^k UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^l Damascus Hospital   (Syrian Arab Republic)

^m ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

ⁿ ISTANBUL UNIVERSITY   (Turkey)

^o CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^p HOSPITAL PABLO TOBÓN URIBE   (Colombia)

^q VILNIUS UNIVERSITY   (Lithuania)

^r JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^s EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^t GAZIANTEP UNIVERSITY   (Turkey)

^u School of Medicine   (Poland)

^v UNIVERSITY CHILDREN S HOSPITAL   (Serbia)

^w Institute of Mother and Child Healthcare of Serbia   (Serbia)

^x HOSPICES CIVILS DE LYON   (France)

^y BASKENT UNIVERSITY   (Turkey)

^z DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^aa MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^ab Unit of Nephrology and Dialysis   (Italy)

^ac UNIVERSITY OF MILAN   (Italy)

^ad Department of Pulmonology   (Poland)

^ae MEDICAL UNIVERSITY OF WARSAW   (Poland)

^af CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^ag UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^ah POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^ai Centro Hospitalar Universitario do Porto   (Portugal)

^aj MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^ak ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^al GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^am DUBAI HOSPITAL   (United Arab Emirates)

^an MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^ao ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL OUTCOME; CONGENITAL NEPHROTIC SYNDROME; DRUG PULSE THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MEDICAL GENETICS; MINIMAL CHANGE GLOMERULONEPHRITIS; PRIORITY JOURNAL; REMISSION; RISK FACTOR; SURVIVAL RATE; TREATMENT RESPONSE; COMPLICATION; FOLLOW UP; INFANT; KIDNEY FAILURE, CHRONIC; NEPHROTIC SYNDROME; PRESCHOOL CHILD; SURVIVAL ANALYSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; KIDNEY FAILURE, CHRONIC; NEPHROTIC SYNDROME; SURVIVAL ANALYSIS;

EID: 85030457670     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2016101121     Document Type: Article

References (40)

1. NAPRTCS: NAPRTCS 2008 Annual Report (Renal Transplantation, Dialysis, Chronic Renal Insufficiency), Rockville, MD, The Emmes Corporation, 2008
2. Büscher AK, Beck BB, Melk A, Hoefele J, Kranz B, Bamborschke D, Baig S, Lange-Sperandio B, Jungraithmayr T, Weber LT, Kemper MJ, Tönshoff B, Hoyer PF, Konrad M, Weber S; German Pediatric Nephrology Association (GPN): Rapid response to cyclosporin A and favorable renal outcome in nongenetic versus genetic steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 11: 245-253, 2016
3. Sadowski CE, Lovric S, Ashraf S, PabstWL, Gee HY, Kohl S, Engelmann S, Vega-Warner V, Fang H, Halbritter J, SomersMJ, TanW, Shril S, Fessi I, Lifton RP, Bockenhauer D, El-Desoky S, Kari JA, Zenker M, Kemper MJ, Mueller D, Fathy HM, Soliman NA, Hildebrandt F; SRNS Study Group: A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol 26: 1279-1289, 2015
4. Cattran DC, Rao P: Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 32: 72-79, 1998
5. Gipson DS, Chin H, Presler TP, Jennette C, Ferris ME, Massengill S, Gibson K, Thomas DB: Differential risk of remission and ESRD in childhood FSGS. Pediatr Nephrol 21: 344-349, 2006
6. Paik KH, Lee BH, Cho HY, Kang HG, Ha IS, Cheong HI, Jin DK, Moon KC, Choi Y: Primary focal segmental glomerular sclerosis in children: Clinical course and prognosis. Pediatr Nephrol 22: 389-395, 2007
7. Abrantes MM, Cardoso LS, Lima EM, Penido Silva JM, Diniz JS, Bambirra EA, Oliveira EA: Predictive factors of chronic kidneydisease in primary focal segmental glomerulosclerosis. Pediatr Nephrol 21: 1003-1012, 2006
8. Abeyagunawardena AS, Sebire NJ, Risdon RA, Dillon MJ, Rees L, Van't Hoff W, Kumarasiri PV, Trompeter RS: Predictors of long-term outcome of children with idiopathic focal segmental glomerulosclerosis. Pediatr Nephrol 22: 215-221, 2007
9. Martinelli R, Okumura AS, Pereira LJ, Rocha H: Primary focal segmental glomerulosclerosis in children: Prognostic factors. Pediatr Nephrol 16: 658-661, 2001
10. Trautmann A, Bodria M, Ozaltin F, Gheisari A, Melk A, AzocarM, Anarat A, Caliskan S, Emma F, Gellermann J, Oh J, Baskin E, Ksiazek J, Remuzzi G, ErdoganO, Akman S, Dusek J, Davitaia T, ÖzkayaO, Papachristou F, Firszt-Adamczyk A, Urasinski T, Testa S, Krmar RT, Hyla-Klekot L, Pasini A, Özcakar ZB, Sallay P, Cakar N, Galanti M, Terzic J, Aoun B, Caldas Afonso A, Szymanik-Grzelak H, Lipska BS, Schnaidt S, Schaefer F; PodoNet Consortium: Spectrum of steroid-resistant and congenital nephrotic syndrome in children: The PodoNet registry cohort. Clin J Am Soc Nephrol 10: 592-600, 2015
11. Mekahli D, Liutkus A, Ranchin B, Yu A, Bessenay L, Girardin E, Van Damme- Lombaerts R, Palcoux JB, Cachat F, Lavocat MP, Bourdat-Michel G, Nobili F, Cochat P: Long-term outcome of idiopathic steroid-resistant nephrotic syndrome: A multicenter study. Pediatr Nephrol 24: 1525-1532, 2009
12. Niaudet P: Pediatric Nephrology, 5th Ed., Philadelphia, Lippincott Williams and Wilkins, 2004 13. Niaudet P; French Society of Pediatric Nephrology: Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. J Pediatr 125: 981-986, 1994
13. Cattran DC, Appel GB, Hebert LA, Hunsicker LG, Pohl MA, Hoy WE, Maxwell DR, Kunis CL; North America Nephrotic Syndrome Study Group: A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. Kidney Int 56: 2220-2226, 1999
14. El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M: Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: A singlecentre experience. Nephrol Dial Transplant 20: 2433-2438, 2005
15. GhiggeriGM, Catarsi P, Scolari F, CaridiG, Bertelli R, CarreaA, Sanna-Cherchi S, Emma F, Allegri L, Cancarini G, Rizzoni GF, Perfumo F: Cyclosporine in patients with steroid-resistant nephrotic syndrome: An open-label, nonrandomized, retrospective study. Clin Ther 26: 1411-1418, 2004
16. Hino S, Takemura T, OkadaM, MurakamiK, YagiK, Fukushima K, Yoshioka K: Follow-up study of children with nephrotic syndrome treated with a longterm moderate dose of cyclosporine. Am J Kidney Dis 31: 932-939, 1998
17. Inaba A, Hamasaki Y, Ishikura K, Hamada R, Sakai T, Hataya H, Komaki F, Kaneko T, Mori M, Honda M: Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children. Pediatr Nephrol 31: 425-434, 2016
18. Plank C, Kalb V, Hinkes B, Hildebrandt F, Gefeller O, Rascher W; Arbeitsgemeinschaft für Pädiatrische Nephrologie: Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome-a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische Nephrologie. Pediatr Nephrol 23: 1483-1493, 2008
19. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr.: Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children. Pediatr Nephrol 10: 590-593, 1996
20. Bajpai A, Bagga A, Hari P, Dinda A, Srivastava RN: Intravenous cyclophosphamide in steroid-resistant nephrotic syndrome. PediatrNephrol 18: 351-356, 2003
21. Hinkes B, Vlangos C, Heeringa S, Mucha B, Gbadegesin R, Liu J, Hasselbacher K, Ozaltin F, Hildebrandt F; APN Study Group: Specific podocin mutations correlate with age of onset in steroid-resistant nephrotic syndrome. J Am Soc Nephrol 19: 365-371, 2008
22. Latta K, von Schnakenburg C, Ehrich JH: A meta-analysis of cytotoxic treatment for frequently relapsing nephrotic syndrome in children. Pediatr Nephrol 16: 271-282, 2001
23. Hodson EM, Willis NS, Craig JC: Interventions for idiopathic steroidresistant nephrotic syndrome in children. Cochrane Database Syst Rev 11: CD003594, 2010
24. Anonymous: Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome. Report of the International study of Kidney Disease in Children. Lancet 2: 423-427, 1974
25. Gargah TT, Lakhoua MR: Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome. JNephrol 24: 203-207, 2011
26. deMello VR, RodriguesMT, Mastrocinque TH, Martins SP, de Andrade OV, Guidoni EB, Scheffer DK, Martini Filho D, Toporovski J, Benini V: Mycophenolate mofetil in children with steroid/cyclophosphamideresistant nephrotic syndrome. Pediatr Nephrol 25: 453-460, 2010
27. Bagga A, Mudigoudar BD, Hari P, Vasudev V: Enalapril dosage in steroid-resistant nephrotic syndrome. Pediatr Nephrol 19: 45-50, 2004
28. Li Z, Duan C, He J, Wu T, XunM, Zhang Y, Yin Y:Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 25: 883-888, 2010
29. Faul C, DonnellyM, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim K, Reiser J, Mundel P: The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 14: 931-938, 2008
30. Gellermann J, Stefanidis CJ, Mitsioni A, Querfeld U: Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations. Pediatr Nephrol 25: 1285-1289, 2010
31. Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F; Arbeitsgemeinschaft Für Pädiatrische Nephrologie Study Group: Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 15: 722-732, 2004
32. Caridi G, Bertelli R, Di Duca M, Dagnino M, Emma F, Onetti Muda A, Scolari F, Miglietti N, Mazzucco G, Murer L, Carrea A, Massella L, Rizzoni G, Perfumo F, GhiggeriGM: Broadening the spectrumof diseases related to podocin mutations. J Am Soc Nephrol 14: 1278-1286, 2003
33. Frishberg Y, Rinat C, Megged O, Shapira E, Feinstein S, Raas- Rothschild A: Mutations in NPHS2 encoding podocin are a prevalent cause of steroid-resistant nephrotic syndrome among Israeli-Arab children. J Am Soc Nephrol 13: 400-405, 2002
34. Weber S, Gribouval O, Esquivel EL, Morinière V, TteMJ, Legendre C, Niaudet P, Antignac C: NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low posttransplant recurrence. Kidney Int 66: 571-579, 2004
35. Lipska BS, Ranchin B, Iatropoulos P, Gellermann J, Melk A, Ozaltin F, Caridi G, Seeman T, Tory K, Jankauskiene A, Zurowska A, Szczepanska M, Wasilewska A, Harambat J, Trautmann A, Peco-Antic A, Borzecka H, Moczulska A, Saeed B, Bogdanovic R, Kalyoncu M, Simkova E, Erdogan O, Vrljicak K, Teixeira A, Azocar M, Schaefer F; PodoNet Consortium: Genotype-phenotype associations in WT1 glomerulopathy. Kidney Int 85: 1169-1178, 2014
36. Malina M, Cinek O, Janda J, Seeman T: Partial remission with cyclosporine Ain a patientwith nephrotic syndrome due to NPHS2mutation. Pediatr Nephrol 24: 2051-2053, 2009
37. Choudhry S, Bagga A, Hari P, Sharma S, Kalaivani M, Dinda A: Efficacy and safety of tacrolimus versus cyclosporine in children with steroidresistant nephrotic syndrome: A randomized controlled trial. Am J Kidney Dis 53: 760-769, 2009
38. Brand JPL: Development, Implementation, and Evaluation of Multiple Imputation Strategies for the Statistical Analysis of Incomplete Data Sets. PhD Thesis, Erasmus University Rotterdam, Netherlands, 1999
39. van Buuren S:Multiple imputation of discrete and continuous data by fully conditional specification. Stat Methods Med Res 16: 219-242, 2007
40. Rubin D: Multiple Imputation for Nonresponse Surveys, New York, John Wiley & Sons, Inc., 1987